Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group

Cancer

Volumn 122, Issue 7, 2016, Pages 1116-1125

  Dupuis, L Lee ^a,b   Lu, Xiaomin ^c   Mitchell, Hannah Rose ^d   Sung, Lillian ^e   Devidas, Meenakshi ^c   Mattano, Leonard A ^f   Carroll, William L ^g   Winick, Naomi ^h   Hunger, Stephen P ⁱ   Maloney, Kelly W ^j   Kadan Lottick, Nina S ^d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f HARP Pharma Consulting   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j CHILDREN S HOSPITAL COLORADO   (United States)

more..

Author keywords

anxiety; childhood acute lymphoblastic leukemia; nausea; pain

Indexed keywords

ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; TIOGUANINE; VINCRISTINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; MACROGOL DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ANXIETY; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE ESCALATION; EDUCATIONAL STATUS; ETHNICITY; FAMILY FUNCTIONING; FAMILY SIZE; FEMALE; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; NAUSEA; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT; CHEMICALLY INDUCED; CONSOLIDATION CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; MAINTENANCE CHEMOTHERAPY; PARENT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE;

6-MERCAPTOPURINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CONSOLIDATION CHEMOTHERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; LONGITUDINAL STUDIES; MAINTENANCE CHEMOTHERAPY; MALE; METHOTREXATE; NAUSEA; PAIN; PARENTS; POLYETHYLENE GLYCOLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; VINCRISTINE;

EID: 84955482946     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29876     Document Type: Article

References (37)

1. Hunger SP, Lu X, Devidas M, et al., Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children's Oncology Group. J Clin Oncol. 2012; 30: 1663-1669.
2. Landier W, Armenian S, Bhatia S,. Late effects of childhood cancer and its treatment. Pediatr Clin North Am. 2015; 62: 275-300.
3. Dupuis LL, Milne-Wren C, Cassidy M, et al., Symptom assessment in children receiving cancer therapy: the parents' perspective. Support Care Cancer. 2010; 18: 281-299.
4. Huijer H, Sagherian K, Tamim H,. Quality of life and symptom prevalence in children with cancer in Lebanon: the perspective of parents. Ann Palliat Med. 2013; 2: 59-70.
5. Sung L, Yanofsky R, Klaassen R, et al., Quality of life during active treatment for pediatric acute lymphoblastic leukemia. Int J Cancer. 2011; 128: 1213-1220.
6. Van Cleve L, Bossert E, Beecroft P, et al., The pain experience of children with leukemia during the first year after diagnosis. Nurs Res. 2004; 53: 1-10.
7. Pirri C, Bayliss E, Trotter J, et al., Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment and concurrently as part of a symptom cluster. Support Care Cancer. 2013; 21: 735-748.
8. Foubert J, Vaesson G,. Nausea: the neglected symptom? Eur J Oncol Nurs. 2005; 9: 21-32.
9. Maloney K, Devidas M, Mattano L, et al., Excellent event free (EFS) and overall survival (OS) for children with standard risk acute lymphoblastic leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an intensified consolidation: results of Children's Oncology Group (COG) AALL0331 [abstract]. Blood. 2013; 122: 837.
10. Myers R, Balsamo L, Lu X, et al., A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia. Cancer. 2014; 120: 1417-1425.
11. Mitchell HR, Lu X, Myers R, et al., Prospective, longitudinal assessment of quality of life in children from diagnosis to three months off treatment for standard risk (SR) acute lymphoblastic leukemia (ALL): results of Children's Oncology Group study AALL0331. Int J Cancer. 2016; 138: 332-339.
12. Smith M, Arthur D, Camitta B, et al., Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996; 14: 18-24.
13. ClinicalTrials.gov. Combination chemotherapy in treating young patients with newly diagnosed acute lymphoblastic leukemia. https://clinicaltrials.gov/show/NCT00103285. Accessed April 1, 2015.
14. Matloub Y, Bostrom B, Hunger S, et al., Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2011; 118: 243-251.
15. Miller I, Epstein N, Bishop D, et al., The McMaster Family Assessment Device-reliability and validity. J Marital Fam Ther. 1985; 11: 345-356.
16. Varni J, Burwinkle T, Katz E, et al., The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002; 94: 2090-2106.
17. Savage E, Riordan A, Hughes M,. Quality of life in children with acute lymphoblastic leukaemia: a systematic review. Eur J Oncol Nurs. 2009; 13: 36-48.
18. Sitaresmi M, Mostert S, Gundy C, et al., Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes. 2008; 6: 96.
19. Tunney AM, Boore J,. The effectiveness of a storybook in lessening anxiety in children undergoing tonsillectomy and adenoidectomy in Northern Ireland. Issues Compr Pediatr Nurs. 2013; 36: 319-335.
20. Brown NJ, Kimble RM, Rodger S, et al., Play and heal: randomized controlled trial of Ditto™ intervention efficacy on improving re-epithelialization in pediatric burns. Burns. 2014; 40: 204-213.
21. Wolyniez I, Rimon A, Scolnik D, et al., The effect of a medical clown on pain during intravenous access in the pediatric emergency department: a randomized prospective pilot study. Clin Pediatr (Phila). 2013; 52: 1168-1172.
22. Hartling L, Newton AS, Liang Y, et al., Music to reduce pain and distress in the pediatric emergency department: a randomized clinical trial. JAMA Pediatr. 2013; 167: 826-835.
23. Andrews P, Sanger G,. Nausea and the quest for the perfect antiemetic. Eur J Pharmacol. 2014; 722: 108-121.
24. Basch E, Prestrud A, Hesketh P, et al., Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2011; 29: 4189-4198.
25. Dupuis L, Boodhan S, Sung L, et al., Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2011; 57: 191-198.
26. Grunberg SM, Deuson RR, Mavros P, et al., Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer. 2004; 100: 2261-2268.
27. Liau CT, Chu NM, Liu HE, et al., Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes. Support Care Cancer. 2005; 13: 277-286.
28. Majem M, Moreno M, Calvo N, et al., Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists. Support Care Cancer. 2011; 19: 1983-1990.
29. Dupuis LL, Boodhan S, Holdsworth M, et al., Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2013; 60: 1073-1082.
30. Phillips R, Gopaul S, Gibson F, et al., Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst Rev. 2010: CD007786.
31. Freedman J, Faerber J, Kang T, et al., Predictors of antiemetic alteration in pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2014; 61: 1798-1805.
32. Tremolada M, Axia V, Pillon M, et al., Parental narratives of quality of life in children with leukemia as associated with the placement of a central venous catheter. J Pain Symptom Manage. 2005; 30: 544-552.
33. Hamidah A, Wong CY, Tamil A, et al., Health-related quality of life (HRQOL) among pediatric leukemia patients in Malaysia. Pediatr Blood Cancer. 2011; 57: 105-109.
34. Waters E, Wake M, Hesketh K, et al., Health-related quality of life of children with acute lymphoblastic leukemia: comparisons and correlations between parent and clinician reports. Int J Cancer. 2003; 103: 514-518.
35. Dores G, Deves S, Curtis R, et al., Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012; 119: 34-43.
36. Coller J, White I, Logan R, et al., Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study. Support Care Cancer. 2015; 23: 1233-1236.
37. Illi J, Miaskowski C, Cooper B, et al., Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine. 2012; 58: 437-447.